Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Mosekilde

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
Ugeskrift for Laeger|January 6, 2006
[Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism]Peter Vestergaard, Lars Rejnmark Nielsen, Leif Mosekilde
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 26, 2004
Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention studyErik Roj Larsen, Leif Mosekilde, Anders Foldspang
European Journal of Endocrinology|August 25, 2011
Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controlsAnne Kristine Amstrup, Lars Rejnmark, Leif Mosekilde
Preventive Medicine|July 1, 2004
Correlates of falling during 24 h among elderly Danish community residentsErik Roj Larsen, Leif Mosekilde, Anders Foldspang
Ugeskrift for Laeger|September 15, 2005
[Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis]Leif Mosekilde, Lars Rejnmark Nielsen, Peter Vestergaard
Aging Clinical and Experimental Research|June 28, 2005
Vitamin D and calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic population-based 3-year intervention studyErik Roj Larsen, Leif Mosekilde, Anders Foldspang
Clinical Endocrinology|November 3, 2010
Determinants of plasma PTH and their implication for defining a reference intervalLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|March 26, 2008
Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis DLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
International Journal of Endocrinology|December 18, 2009
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
Clinical Endocrinology|September 22, 2015
Pseudohypoparathyroidism - epidemiology, mortality and risk of complicationsLine Underbjerg, Tanja Sikjaer, Leif Mosekilde, et al.
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
Ugeskrift for Laeger|January 6, 2006
[Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism]Peter Vestergaard, Lars Rejnmark Nielsen, Leif Mosekilde
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 26, 2004
Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention studyErik Roj Larsen, Leif Mosekilde, Anders Foldspang
European Journal of Endocrinology|August 25, 2011
Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controlsAnne Kristine Amstrup, Lars Rejnmark, Leif Mosekilde
Preventive Medicine|July 1, 2004
Correlates of falling during 24 h among elderly Danish community residentsErik Roj Larsen, Leif Mosekilde, Anders Foldspang
Ugeskrift for Laeger|September 15, 2005
[Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis]Leif Mosekilde, Lars Rejnmark Nielsen, Peter Vestergaard
Aging Clinical and Experimental Research|June 28, 2005
Vitamin D and calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic population-based 3-year intervention studyErik Roj Larsen, Leif Mosekilde, Anders Foldspang
Clinical Endocrinology|November 3, 2010
Determinants of plasma PTH and their implication for defining a reference intervalLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
European Journal of Endocrinology|March 26, 2008
Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis DLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
International Journal of Endocrinology|December 18, 2009
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trialLars Rejnmark, Peter Vestergaard, Lene Heickendorff, et al.
Clinical Endocrinology|September 22, 2015
Pseudohypoparathyroidism - epidemiology, mortality and risk of complicationsLine Underbjerg, Tanja Sikjaer, Leif Mosekilde, et al.
Pageof 16